Hao Xia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hao Xia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bin Wang
Department of Geriatrics Union Hospital Tongji Medical CollegeHuazhong University of Science and Technology Wuhan China
1 shared publication - Bo Li
Department of Cardiology Affiliated Hospital of Jiangsu University Zhenjiang China
1 shared publication Chong Xu
Department of Cardiology Affiliated Hospital of Jiangsu University Zhenjiang China
1 shared publicationHongxia Xia
Department of Emergency, East Campus Renmin Hospital of Wuhan University Wuhan China
1 shared publicationHui Zhao
Department of Interventional Radiology Renmin Hospital of Wuhan University Wuhan China
1 shared publicationJie Wei
Department of Emergency, East Campus Renmin Hospital of Wuhan University Wuhan China
1 shared publication
Latest Publications
- 24 November 2021
- Published by Wiley in Cell Biology International
- Vol. 46 (2) , 243-254
MiR‐195‐5p represses inflammation, apoptosis, oxidative stress, and endoplasmic reticulum stress in sepsis‐induced myocardial injury by targeting activating transcription factor 6
Myocardial injury (MI) is a common complication of sepsis. MicroRNAs (miRNAs) have been suggested as potential biomarkers of MI; however, their mechanisms in sepsis‐induced MI remain unclear. A sepsis rat model was constructed by use of cecal ligation and puncture (CLP). The levels of miR‐195‐5p and activating transcription factor 6 (ATF6) expression were determined by quantitative reverse‐transcription polymerase chain reaction, and cytokine levels were detected by ELISA. The levels of oxidative stress (OS)‐related indicators and endoplasmic reticulum stress (ERS)‐related proteins were examined, and the regulatory effect of miR‐195‐5p on ATF6 was determined by using the luciferase reporter assay. Our results showed that miR‐195‐5p expression was downregulated and ATF6 expression was upregulated in lipopolysaccharide‐induced cardiomyocytes and mice with CLP‐induced sepsis. We also found that miR‐195‐5p could markedly attenuate the inflammation, apoptosis, OS, and ERS associated with sepsis‐induced MI. Additionally, we verified that miR‐195‐5p could relieve sepsis‐induced MI by targeting ATF6. This study identified potential targets for treating MI after sepsis.
- 24 November 2021
- Published by Wiley in Cell Biology International
- Vol. 46 (2) , 243-254
MiR‐195‐5p represses inflammation, apoptosis, oxidative stress, and endoplasmic reticulum stress in sepsis‐induced myocardial injury by targeting activating transcription factor 6
Myocardial injury (MI) is a common complication of sepsis. MicroRNAs (miRNAs) have been suggested as potential biomarkers of MI; however, their mechanisms in sepsis‐induced MI remain unclear. A sepsis rat model was constructed by use of cecal ligation and puncture (CLP). The levels of miR‐195‐5p and activating transcription factor 6 (ATF6) expression were determined by quantitative reverse‐transcription polymerase chain reaction, and cytokine levels were detected by ELISA. The levels of oxidative stress (OS)‐related indicators and endoplasmic reticulum stress (ERS)‐related proteins were examined, and the regulatory effect of miR‐195‐5p on ATF6 was determined by using the luciferase reporter assay. Our results showed that miR‐195‐5p expression was downregulated and ATF6 expression was upregulated in lipopolysaccharide‐induced cardiomyocytes and mice with CLP‐induced sepsis. We also found that miR‐195‐5p could markedly attenuate the inflammation, apoptosis, OS, and ERS associated with sepsis‐induced MI. Additionally, we verified that miR‐195‐5p could relieve sepsis‐induced MI by targeting ATF6. This study identified potential targets for treating MI after sepsis.
- Open Access
- 1 June 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (11) , e020721
Contributions of Costimulatory Molecule CD137 in Endothelial Cells
CD137 (4‐1BB, tumor necrosis factor receptor superfamily 9) is a surface glycoprotein of the tumor necrosis factor receptor family that can be induced on a variety of immunocytes and nonimmune cells, including endothelial cells and smooth muscle cells. The importance of CD137 in immune response has been well recognized; however, the precise biological effects and underlying mechanisms of CD137 in endothelial cells are unclear. A single layer of cells called the endothelium constitutes the innermost layer of blood vessels including larger arteries, veins, the capillaries, and the lymphatic vessels. It not only acts as an important functional interface, but also participates in local inflammatory response. This review covers recent findings to illuminate the role of CD137 in endothelial cells in different pathophysiologic settings.
- 1 June 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (11) , e020721
Open AccessContributions of Costimulatory Molecule CD137 in Endothelial Cells
CD137 (4‐1BB, tumor necrosis factor receptor superfamily 9) is a surface glycoprotein of the tumor necrosis factor receptor family that can be induced on a variety of immunocytes and nonimmune cells, including endothelial cells and smooth muscle cells. The importance of CD137 in immune response has been well recognized; however, the precise biological effects and underlying mechanisms of CD137 in endothelial cells are unclear. A single layer of cells called the endothelium constitutes the innermost layer of blood vessels including larger arteries, veins, the capillaries, and the lymphatic vessels. It not only acts as an important functional interface, but also participates in local inflammatory response. This review covers recent findings to illuminate the role of CD137 in endothelial cells in different pathophysiologic settings.